Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Assets Average (2016 - 2025)

Historic Assets Average for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to $501.7 million.

  • CorMedix's Assets Average rose 64156.4% to $501.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.7 million, marking a year-over-year increase of 64156.4%. This contributed to the annual value of $65.5 million for FY2022, which is 1076.49% up from last year.
  • Per CorMedix's latest filing, its Assets Average stood at $501.7 million for Q3 2025, which was up 64156.4% from $201.1 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Assets Average peaked at $501.7 million during Q3 2025, and registered a low of $58.1 million during Q2 2023.
  • Over the past 5 years, CorMedix's median Assets Average value was $69.9 million (recorded in 2021), while the average stood at $105.5 million.
  • In the last 5 years, CorMedix's Assets Average plummeted by 1964.36% in 2022 and then soared by 64156.4% in 2025.
  • CorMedix's Assets Average (Quarter) stood at $72.2 million in 2021, then fell by 14.01% to $62.1 million in 2022, then increased by 19.62% to $74.2 million in 2023, then surged by 32.31% to $98.2 million in 2024, then skyrocketed by 410.84% to $501.7 million in 2025.
  • Its Assets Average was $501.7 million in Q3 2025, compared to $201.1 million in Q2 2025 and $134.2 million in Q1 2025.